Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease. - Wikidata - awgldk - TriplyDB

Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.

Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.

http://www.wikidata.org/entity/Q41847394

about

Immune dysfunction in uremia—an update Paraprotein-Related Kidney Disease: Diagnosing and Treating Monoclonal Gammopathy of Renal Significance.Association of urinary laminin G-like 3 and free K light chains with disease activity and histological injury in IgA nephropathy.Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure.Association between abnormal serum free light chains ratio and known prognostic factors in lymphoma; a nephrology viewpoint.Serum immunoglobulin free light chain measurements and heavy chain isotype usage provide insight into disease biology in patients with POEMS syndrome.Prevalence and risk of progression of light-chain monoclonal gammopathy of undetermined significance: a retrospective population-based cohort study Polyclonal light chains in cerebrovascular disease Covalent binding antibodies suppress advanced glycation: on the innate tier of adaptive immunity.Diagnostic accuracy of monoclonal antibody based serum immunoglobulin free light chain immunoassays in myeloma cast nephropathy Estimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney disease Early reduction of serum-free light chains associates with renal recovery in myeloma kidney.Immunoglobulin light chains activate tubular epithelial cells through redox signaling.Monoclonal and polyclonal serum free light chains and clinical outcome in chronic lymphocytic leukemia.Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD Serum free light chains and the risk of ESRD and death in CKD The Association between Polyclonal Combined Serum Free Light Chain Concentration and Mortality in Individuals with Early Chronic Kidney Disease.Daily postdilutional hemodiafiltration with FX800 polysulfone dialyzers for removing kappa light chains in multiple myeloma-induced kidney injury Circulating antibody free light chains and risk of posttransplant lymphoproliferative disorder.The pathogenesis and diagnosis of acute kidney injury in multiple myeloma.Elevated urinary excretion of immunoglobulins in nonproteinuric patients with type 1 diabetes.Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.CD163 and c-Met expression in the lymph node and the correlations between elevated levels of serum free light chain and the different clinicopathological parameters of advanced classical Hodgkin's lymphoma.Serum Immunoglobulin Free Light Chain Assessment in IgG4-Related Disease.Screening panels for detection of monoclonal gammopathies.Association between free light chain levels, and disease progression and mortality in chronic kidney disease.Kidney disease associated with plasma cell dyscrasias Renal failure in multiple myeloma: a medical emergency.Novel approaches for reducing free light chains in patients with myeloma kidney.Kidney disease and multiple myeloma.Serum free light chain analysis in the diagnosis and management of multiple myeloma and related conditions.Proteomic analysis of adipose tissue: informing diabetes research.The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease.The importance of screening for serum free light chains in suspected cases of multiple myeloma and their impact on the kidney.Proteomic biomarkers in kidney disease: issues in development and implementation.Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma.Recurrent proliferative glomerulonephritis with monoclonal immunoglobulin G deposits leads to rapid graft loss after kidney transplantation: a case report.Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions.Durable remission of C3 glomerulonephritis with mycophenolate mofetil.Addressing Common Questions Encountered in the Diagnosis and Management of Cardiac Amyloidosis.

P2860

Q26829076-569375C1-19D6-419C-879A-B0A834DCA5AA Q30276115-3E247A72-62B7-4093-9F59-48063F1BE113 Q31115552-E79113BE-2C9A-487C-A30A-D0FB911A8234 Q33371085-8E7A25BF-6CDD-4F52-B2EA-D3C3647F392C Q33652326-66EC868A-710A-4E48-93CC-6D0172527036 Q33988217-C5D29DAD-7437-4D9B-B523-730455B72914 Q33997173-82592580-B52C-4769-B734-7D3AF99E9872 Q34122999-24668AE0-A109-4E33-90FF-35144B9F1A3F Q34287672-A11F5174-71A0-4407-8C2B-10F89B4F4E7E Q34370957-A81538AD-EE94-4824-A8EE-0664F777FBB8 Q34406428-C87E0265-B9A9-44B3-8700-BE0705529737 Q35012436-0CCE2880-CB67-4212-BC15-C14D2DA28CE2 Q35153211-ABF13B99-3E12-459B-A4E9-A8D8133EA0AE Q35212377-07B1DC1E-3E7B-40DC-B77A-3E082C04606C Q35576138-D90AF376-9741-43C6-9B5A-0090E1B9BCDC Q35664565-B9255E90-23AD-4619-991C-6727FE661C71 Q35680192-DC89A77B-1C35-4F6D-9D11-D12285AC8B6E Q35830287-42FB822E-EDB0-4510-826F-F35EC02F36E6 Q35918672-4639AE83-CC68-4407-B9B6-2ED86B7DD5AB Q36033448-0D567212-B12A-45F3-A272-95BF916A15AC Q36200281-60EDFEC9-91B0-440C-A7AF-0330A69E1DA3 Q36325334-DF960585-AE97-462B-A06C-6BA54828D417 Q36973329-45AE1BC4-DEBF-4221-8816-B0E3B89CC831 Q37009888-FDFED514-313B-477C-B914-F28203B41C12 Q37172007-AE2A3AE6-BC7C-43AB-97C0-255F7D553547 Q37357864-6123A0B5-F06A-46A2-83D2-2362C506BF8E Q37750106-B57CF7C9-B8BB-46BE-A273-943EC6EED099 Q37845643-AFD7A88E-15C1-4223-A1B8-E9E264B25701 Q37986358-66CB306B-63C6-46ED-A293-5F2FD703B510 Q38122674-C8DF78F4-0AB2-4E6C-804C-92F13396F4ED Q38168869-E2FEAC26-A4E8-44F5-B84A-B76FC73FEF52 Q38200652-669B56D6-5220-48E6-9E59-E11E9D656B00 Q38258148-2CC1C208-2BA9-4FC0-81FE-D449761AF89F Q38261185-D7FC0D8E-8D93-4DC2-9BE0-9D3631A2D487 Q38341211-99387E6A-B8E8-4EF9-8F6A-B1A68C7578B5 Q38398899-02BBECF2-1167-4A62-9149-C5B1E98F7315 Q38783773-475C7DCC-5BAA-44A7-B81F-F21DB9E03571 Q38911216-001D0AD3-E8E5-48B9-8F14-2B88AE8965C1 Q39125632-1104B0D8-74DC-4F93-8F6E-E8DF85EEFB10 Q39217713-4C31BAF7-3CAB-4435-BE32-9DA398B909F3

P2860

Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.

http://www.wikidata.org/entity/Q41847394

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Quantitative assessment of ser ...... s with chronic kidney disease.

@en

type

label

Quantitative assessment of ser ...... s with chronic kidney disease.

@en

prefLabel

Quantitative assessment of ser ...... s with chronic kidney disease.

@en

P1433

Q41847394-3A2DEDE9-9D58-4E6A-A147-196D799BA252

P1476

Q41847394-9CA88435-E826-4668-B155-965E8C30F0FF

P2093

Q41847394-04D184E0-20C4-43F1-ACE6-FD743F3F5EFB

Q41847394-06923F7D-15AF-406A-9453-63EF08BE80DF

Q41847394-15722E5C-E908-457A-8702-5FA6B379A5C2

Q41847394-5C4A2DBD-0424-40B3-A594-CB169CEBD7C3

Q41847394-7A602CF4-D1C4-4E25-993F-8F20D06CCD24

Q41847394-A4A6F95A-3A30-4EA8-B476-A628F510E14C

P2860

Q41847394-026D07B5-1928-4915-973E-AD5A24E0961D

Q41847394-1906AFA5-D501-4539-BB4D-74DA9C0143FE

Q41847394-1F97C2B1-3998-4FD4-BE3F-53056E94F4D9

Q41847394-21E836FB-00BC-45CF-B814-BE7914794632

Q41847394-27887995-0144-4729-B9E7-7878BCF8A636

Q41847394-33FF6E03-CAA0-4C6E-9E13-AB15BEBE3B82

Q41847394-4744EBF4-E727-4995-98F5-73CFA576AD10

Q41847394-4D82F781-90E4-4202-AAB2-8262BA7594BD

Q41847394-5509B377-3829-4525-B184-80F60E822C2A

Q41847394-5C25303C-9DB8-460B-BA3C-77F343A1111C

P304

Q41847394-C628788F-4644-45C9-B7D2-B2ED138E30FC

P31

Q41847394-4C703850-76A9-447A-A7C0-DA9191A7D02C

P356

Q41847394-4E4C671F-F9E7-4006-BE7C-6DC18D81BF97

P433

Q41847394-EE53DE76-790B-45C1-8ACF-C906A836D63D

P478

Q41847394-C49EA7E1-6A3A-4BAB-A276-69C8AE54DA06

P50

Q41847394-F54B5515-6212-4560-ABB8-3605E33A5F3F

P577

Q41847394-F2DD6E7C-B10A-49AE-A4E6-135EC088A02F

P698

Q41847394-B3C0B87C-B8ED-4EDF-8360-BA732DF57741

P932

Q41847394-EC465845-46AA-43FD-B950-3BD87AD3BDEC

P356

P1433

Clinical Journal of the American Society of Nephrology

P1476

Quantitative assessment of ser ...... s with chronic kidney disease.

@en

P2093

Arthur R Bradwell

http://www.w3.org/2001/XMLSchema#string

Colin A Hutchison

http://www.w3.org/2001/XMLSchema#string

Graham P Mead

http://www.w3.org/2001/XMLSchema#string

John Townsend

http://www.w3.org/2001/XMLSchema#string

Pete Hewins

http://www.w3.org/2001/XMLSchema#string

Stephen Harding

http://www.w3.org/2001/XMLSchema#string

P2860

Pathobiology of cast nephropathy from human Bence Jones proteins

The renal handling of low molecular weight proteins. II. Disorders of serum protein catabolism in patients with tubular proteinuria, the nephrotic syndrome, or uremia

Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains

Prediction of creatinine clearance from serum creatinine

Uremic toxins modulate the spontaneous apoptotic cell death and essential functions of neutrophils.

Highly sensitive, automated immunoassay for immunoglobulin free light chains in serum and urine.

Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory.

Correlation of serum immunoglobulin free light chain quantification with urinary Bence Jones protein in light chain myeloma.

Serum free light chain analysis and urine immunofixation electrophoresis in patients with multiple myeloma.

International uniform response criteria for multiple myeloma.

P304

1684-1690

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2215/CJN.02290508

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18945993

http://www.w3.org/2001/XMLSchema#string

P932

2572283

http://www.w3.org/2001/XMLSchema#string